CSS LLC’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

CSS LLC’s Portfolio KDNY Stock Details KDNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-32,291	Closed	-$1.24M	–	1042
2023 Q2	$1.24M	Buy	+32,291	New	+$829K	0.08%	194

CSS LLC's KDNY Position: Q3 2023 in Review

CSS LLC sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q3 2023, closing a stake of 32,291 shares — an estimated $1.24M sold.

CSS LLC first reported a position in KDNY in Q2 2023 and held it in 1 quarter. The position peaked at $1.24M in Q2 2023. 2 funds tracked by Wall St. Rank hold KDNY as of Q3 2023.

CSS LLC reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
CSS LLC sold 32,291 Chinook Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $1.24M.
CSS LLC first reported a position in Chinook Therapeutics, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
CSS LLC's Chinook Therapeutics, Inc. Common Stock position peaked at $1.24M in Q2 2023.
2 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q3 2023.

Based on CSS LLC's 13F filing for Q3 2023, filed 14 Nov 2023.